RE: Brokers27 Oct 2022 11:32
Was just shy of £12 last july, tests that have been sold in US are largely reimbursed at $950 each(not bad) , business has had $30M finance package earlier in year to see them through to March 2024, so plenty in there and let's not forget that approximately 2/3rd of the finance raised through convertible bonds is at a 20% premium to into Renalytix ADS at $8.70 per ADS, nice. Like any business, they have to spend and it is more necessary in their line of business as a growth company, so confidence in management to delivery as they have over 200 years combined experience.